Clora

578 posts

Clora banner
Clora

Clora

@MeetClora

The best place to discover, build, and manage on-demand life science teams.

Boston, MA انضم Eylül 2015
260 يتبع191 المتابعون
Clora
Clora@MeetClora·
Biotech doesn’t have a hiring problem—it has a #resourcing strategy problem. Only 48% of talent needs are met, while specialized roles take 100+ days to fill. Leading companies are rethinking work, bringing in #expertise on demand and prioritizing flexibility to stay on track.
Clora tweet media
English
0
0
1
32
Clora
Clora@MeetClora·
In #biotech and #pharma, speed has been seen as a tradeoff with quality—but that’s changing. Progress now depends on fast access to the right #expertise. Leading teams use agile #talent models to tap global experts on demand, accelerating timelines without compromising rigor.
Clora tweet media
English
0
0
0
15
Clora
Clora@MeetClora·
Which #resourcing model gives you speed, control, and quality? FTEs take 100+ days. CROs lack flexibility. See how #consultants deliver expertise without delays. Download our free reports to compare your options: ow.ly/pF9150YvZfA
Clora tweet media
English
0
0
0
10
Clora
Clora@MeetClora·
Clora CEO @rahulc speaks with physician-scientist and #biotech founder Sheila Gujrathi, MD, about her path through biotech #leadership, building companies, and the lessons she’s learned along the way. Listen to the #podcast now.
Biotech2050 Podcast@Biotech2050Pod

This episode is sponsored by @Quartzy. Sheila Gujrathi, MD joins @rahulc on #Biotech2050 to discuss leadership, venture building, & lessons from her book The Mirror Effect on confidence, leadership & navigating power in biotech 🎧 on.soundcloud.com/RPVtOCG58wdb7k… #TheMirrorEffect #biotech

English
0
0
1
15
Clora
Clora@MeetClora·
Biotech #IPOs may be making a comeback in 2026. After peaking with 87 U.S. #biotech IPOs in 2021, activity dropped to just 11 in 2025. Now momentum may be returning as more companies begin entering the public markets: ow.ly/fmho50YpNil
English
0
0
0
9
Clora
Clora@MeetClora·
JPM 2026 signaled renewed optimism for #biopharma. Deals are expected to center on late-stage pipelines/assets, while R&D priorities move toward more prevalent diseases over rare/orphan indications. Read more from @BioSpace: ow.ly/Q5Cz50YlbFC
English
0
0
0
7
Clora
Clora@MeetClora·
.@bainalerts highlights 4 trends reshaping deal strategy: vertical integration for speed and control, next-gen obesity assets, continued momentum in ADCs, & growing cross-border opportunity in Greater China. Differentiation—not scale—is driving M&A: ow.ly/UOMK50Yfmp9
English
0
0
0
14
Clora
Clora@MeetClora·
Big congrats to our client, Parabilis Medicines, on closing a $305M Series F to advance their Helicon™ medicines, including a Phase 3 trial for FOG-001 in desmoid tumors. A big move in targeting tough-to-treat cancers. Read more in their press release: ow.ly/9XNy50Y0BOi
English
0
0
1
39
Clora
Clora@MeetClora·
We’re proud to support our client as Somite becomes @CellularIntelHQ, building the first universal virtual cell-signaling model to guide, not just map, #biology. A bold step toward predictive, programmable #cellbehavior.
Micha Breakstone 🇮🇱🎗️@MichaBreakstone

Somite is now Cellular Intelligence. More than a rebrand, this reflects what our team has been building over the last two years: the first universal virtual cell signaling model, designed to understand, predict, and ultimately control cell behavior. To further mark this step forward, we’re releasing a new white paper that shares our technical progress and maps out what is to come: cellularintelligence.com/science Deeply proud of our team for daring to turn an implausible idea into reality. Dive into what we’re creating at @CellularIntelHQ today: cellularintelligence.com

English
0
0
0
21
Clora
Clora@MeetClora·
Will you be in the Bay Area for #JPM2026 next week? Our CEO @rahulc will be there and would love to connect. Learn how #Clora is helping #lifesciences companies advance programs faster without the long-term cost of traditional #hiring. Drop a comment to set up a meeting!
Clora tweet media
English
0
0
2
78
Clora
Clora@MeetClora·
As we close out the year, we want to extend our gratitude to the life science professionals and companies we’ve had the privilege to work with. Thank you for making 2025 a year of innovation, collaboration, and growth. Wishing you a joyful holiday season and a Happy New Year.
English
0
0
0
15
Clora
Clora@MeetClora·
Will you be in the Bay Area during #JPM2026 next month? Meet with our CEO @rahulc to learn how #Clora is helping companies accelerate development without the capital commitment of traditional #hiring. Request a meeting in the comments below or send us a message.
Clora tweet media
English
0
0
2
89
Clora
Clora@MeetClora·
New @Biotech2050Pod episode: Clora CEO @rahulc talks with John Lepore, CEO of @ProFoundTx, on leading in #biotech, uncovering the human proteome, and using #AI to unlock new drug targets. A look into the next frontier of #medicine. Listen using the link below.
Biotech2050 Podcast@Biotech2050Pod

The episode is sponsored by @Quartzy. 🔬 “What if we’ve only mapped a fraction of human proteins?” @rahulc interviews John Lepore, CEO of @ProFoundTx, on AI, risk-taking, & the next frontier of first-in-class medicines powered by the expanded proteome. 🎧 on.soundcloud.com/xmG2cQ8FBpkURs…

English
0
0
0
14
Clora
Clora@MeetClora·
Biotech VC funding jumped 70.9% in Q3 2025, from $1.8B to $3.1B. Series D saw the biggest leap, up nearly 60x to $832M, a strong signal of renewed investor confidence amid ongoing challenges. Read more: ow.ly/3atQ50XzZYS #biotech #venturecapital #biotechfunding
English
0
0
0
13
Clora
Clora@MeetClora·
🎙️ @JTananbaum, CEO of @ForesiteCapital, joins Clora CEO @rahulc to explore #biotech innovation, #AI in #drugdiscovery, and investing through market cycles. A must-listen on strategy, #science, and impact. Listen using the link below.
Biotech2050 Podcast@Biotech2050Pod

💸 Interest rates 🤖 AI 🧠 Human insight All shaping the future of biotech. 🎙️ @JTananbaum, Founder & CEO of @foresitecapital, joins @rahulc on #Biotech2050 to unpack venture cycles, AI’s rise in drug discovery, & next wave of innovation. 🎧 Listen now →on.soundcloud.com/QtQ8QCZskzFdFa…

English
0
0
0
15
Clora
Clora@MeetClora·
Clora is heading to JPM 2026! Our CEO @rahulc will be in SF and open to meetings. Let’s talk about solving talent gaps with fractional expertise and accelerating development without traditional hiring costs. Send us a message to request a meeting. #JPM2026 #Clora #LifeSciences
Clora tweet media
English
1
0
0
183
Clora
Clora@MeetClora·
Clora CEO @rahulc joins Geoffrey Duyk, CEO of Grove Biopharma, to talk #biotech headwinds, R&D inefficiencies, and synthetic protein mimetics tackling “undruggable” targets. Don’t miss this @Biotech2050Pod episode. Listen now using the link below.
Biotech2050 Podcast@Biotech2050Pod

Biotech’s next wave is polymer-powered. 💥 @rahulc talks w/ Geoffrey Duyk, CEO of Grove Biopharma, on tackling “intractable” targets, fixing R&D inefficiency, & rebuilding trust in science. 🎧 Listen and learn more: on.soundcloud.com/XSF8A7QqSYQJAl… #Biotech2050 #DrugDiscovery #Innovation

English
0
0
1
16
Clora
Clora@MeetClora·
Congratulations to Clora client @CirclePharma on their partnership with @EliLillyandCo to accelerate oral macrocycle drug development. Read more in their press release: ow.ly/x6Ep50WXBu5 #biotech #drugdiscovery #lifesciences #pharma
Circle Pharma@CirclePharma

We are excited to announce an agreement with @EliLillyandCo that enables Circle Pharma to use Lilly TuneLab, a pioneering #AI and #ML platform designed to accelerate the development of new medicines. Read the full press release: circlepharma.com/circle-pharma-…

English
0
0
1
34

اكتشف

@rahulc @BioSpace @bainalerts @Perspective_Tx @LineageCell @FiercePharma @CellularIntelHQ @Biotech2050Pod